[Treatment of XXXX after nerve-preserving radical retropubic prostatectomy].

@entity1 @entity7856 @entity323 @entity9498
The aim of the study was evaluation of erectile function (EF) recovery and effects of @entity7856 inhibitor @entity9498 in the treatment of erectile impairment one year after conduction of nerve-preserving retropubic radical prostatectomy (RRP). Thirty @entity1 with intact EF before surgery who had RRP were divided into two groups. In 18 @entity1 of group I vasculonervous fascicles (VNF) were preserved on both sides. A unilateral nerve-preserving technique was used in 12 @entity1 of group 2. @entity9498 administration was started 3 months after operation in the dose 20 mg. In group I partial erection was observed in 11 @entity1 , was absent in 33% (6 @entity1 ), a complete erection was in one (6%) @entity1 . Thus, 67% (12 @entity1 ) could maintain erection sufficient for coitus. Out of 12 @entity1 of group 2, a complete erection was achieved in none @entity1 , partial erection was observed in 5 (42%) @entity1 , erection did not occur in 7 (58%) @entity1 . Thus, EF is better in @entity1 with bilateral preservation of VNF than in unilateral one. Pharmacotherapy of @entity323 after nerve-preserving RRP is most effective. It is desirable to adhere to early postoperative policy in the treatment of EF. @entity7856 inhibitors are rather effective if the @entity1 has a partial erection. They fail in the absence of spontaneous erections. Early therapy prevents subsequent progression of @entity323 .
